Not Tagged
Not Tagged
['cross tumor']
almost no coverage on my feed, but lots of interesting data at #asco22 on io+soc (if any) in neoadjuvant setting, across tumors types. also discussions on endpoints (pcr, efs), showing that things are moving.
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)